Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 13, 2025
- Accession no.
- 0001106578-25-000030
- Filed
- Nov 13, 2025
- Trade date
- Nov 12-13, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.76M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −500 | $455.97 | −$227,985 | 3,630 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −520 | $457.54 | −$237,920.8 | 3,110 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −980 | $458.71 | −$449,535.8 | 2,130 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −800 | $461.14F2 | −$368,912 | 1,330 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −200 | $462.02 | −$92,404 | 1,130 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −1,000 | $463.24 | −$463,240 | 130 | Direct | |
| Nov 13, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −761 | $458.48 | −$348,903.28 | 3,369 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,299 | $461.17F3 | −$599,059.83 | 2,070 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −1,290 | $1,290.00F4 | −$1,664,100 | 780 | Direct | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −650 | $467.39F5 | −$303,803.5 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 102,000 | Direct | |
| Nov 13, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 98,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $460.96 to $461.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $460.88 to $461.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $466.045 to $466.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $167.195 to $467.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.